Company: IMCR
Filing Date: 2025-03-24
Form Type: PRE 14A
Source: 0001140361-25-010035
Chunk: 122

Company: Immunocore Holdings plc
Filing Date: 2025-03-24
Form: PRE 14A
Chunk 122
---
 the officer’s continued service through each vesting date. |

| 4. | The Non-Executive Director options vest as follows: |

| • | Awards Granted in 2024, 2023 and 2022: Other than for Mr. Kaul’s 2022 award (described in note 5 below) and Mr. Krishana’s 2024 award (described in note 6 below), these option awards become fully vested on the one-year anniversary of the grant date. |

| • | Awards Granted Prior to 2021: These pre-IPO awards were fully vested on the date of grant. |

| 7. | The exercise price of all option awards is equal to the market value at the date of grant, and accordingly there is no value to the recipients at the point of grant. The face value of awards granted in the years ended have been calculated by multiplying the share price at the date of grant by the number of options granted. |

| 8. | Travis Coy and Robert Perez were originally nominated to our board of directors by Eli Lilly S.A. and General Atlantic, respectively, pursuant to our pre-IPO fundraising arrangements, which granted a right to each of Eli Lilly S.A. and General Atlantic to appoint an individual to our board. Both directors elected to forgo remuneration in respect of their services as non-executive directors. |

Payments to Past Directors and Loss of Office No payments were made to former directors of the Company or in relation to loss of office during the year. Directors’ Shareholding and Share Interests The share interests of each Director as of 31 December 2024 (together with interests held by his or her connected persons) are set out in the table below. Directors are encouraged to build up a shareholding but currently no formal shareholding requirements apply. Details of share options award to the CEO and Non-Executive Directors, as of 31 December 2024 are set out in the Share options table provided earlier in this Remuneration Report.

| Director                 |     |  Interest 
 in Shares |     |  Options vested 
 but unexercised |     | Unvested 
  options |     |       Total 
  beneficial 
 interest in 
      shares |     |   Options 
 Vested in 
  the Year |     | Options      
 Exercised in 
 the Year     |
| Executive Director:      |     |           |     |                 |     |          |     |             |     |           |     |